Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Therapeutic Exercise and Long-term Docosahexaenoic Acid (DHA) Supplementation on Physical, Physiological, Motor, Mental, and Cognitive Variables in Patients With Multiple Sclerosis.

NCT07346703 is registered in ClinicalTrials.gov with Francisco Javier Martínez Noguera as lead sponsor.

NCT NCT07346703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07346703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Therapeutic Exercise and Long-term Docosahexaenoic Acid (DHA) Supplementation on Physical, Physiological, Motor, Mental, and Cognitive Variables in Patients With Multiple Sclerosis.
Lead sponsor
Francisco Javier Martínez Noguera
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 31, 2026
Completion date
July 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

function improvement, intervention study, multiple sclerosis, performance enhancement, strength outcomes, supplemental nutrition assistance program education